363 related articles for article (PubMed ID: 30675745)
1. Flaminal® versus Flamazine® in the treatment of partial thickness burns: A randomized controlled trial on clinical effectiveness and scar quality (FLAM study).
Rashaan ZM; Krijnen P; Kwa KAA; van der Vlies CH; Schipper IB; Breederveld RS
Wound Repair Regen; 2019 May; 27(3):257-267. PubMed ID: 30675745
[TBL] [Abstract][Full Text] [Related]
2. Clinical effectiveness, quality of life and cost-effectiveness of Flaminal® versus Flamazine® in the treatment of partial thickness burns: study protocol for a randomized controlled trial.
Rashaan ZM; Krijnen P; van den Akker-van Marle ME; van Baar ME; Vloemans AF; Dokter J; Tempelman FR; van der Vlies CH; Breederveld RS
Trials; 2016 Mar; 17(1):122. PubMed ID: 26945575
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of 1% silver sulphadiazine (Flammazine®) versus an enzyme alginogel (Flaminal®) in the treatment of partial thickness burns.
Hoeksema H; Vandekerckhove D; Verbelen J; Heyneman A; Monstrey S
Burns; 2013 Sep; 39(6):1234-41. PubMed ID: 23523226
[TBL] [Abstract][Full Text] [Related]
4. Long-term quality of life and cost-effectiveness of treatment of partial thickness burns: A randomized controlled trial comparing enzyme alginogel vs silver sulfadiazine (FLAM study).
Rashaan ZM; Krijnen P; Kwa KA; van Baar ME; Breederveld RS; van den Akker-van Marle ME
Wound Repair Regen; 2020 May; 28(3):375-384. PubMed ID: 32022363
[TBL] [Abstract][Full Text] [Related]
5. Flaminal versus Flamazine by Rashaan et al WRR 2019.
White R
Wound Repair Regen; 2019 Sep; 27(5):591-592. PubMed ID: 30977254
[No Abstract] [Full Text] [Related]
6. Clinical effectiveness of alginate silver dressing in outpatient management of partial-thickness burns.
Opasanon S; Muangman P; Namviriyachote N
Int Wound J; 2010 Dec; 7(6):467-71. PubMed ID: 20860635
[TBL] [Abstract][Full Text] [Related]
7. A prospective, randomized trial of silver containing hydrofiber dressing versus 1% silver sulfadiazine for the treatment of partial thickness burns.
Muangman P; Pundee C; Opasanon S; Muangman S
Int Wound J; 2010 Aug; 7(4):271-6. PubMed ID: 20528992
[TBL] [Abstract][Full Text] [Related]
8. Topical petrolatum gel alone versus topical silver sulfadiazine with standard gauze dressings for the treatment of superficial partial thickness burns in adults: a randomized controlled trial.
Genuino GA; Baluyut-Angeles KV; Espiritu AP; Lapitan MC; Buckley BS
Burns; 2014 Nov; 40(7):1267-73. PubMed ID: 25172229
[TBL] [Abstract][Full Text] [Related]
9. Randomized Controlled Trial of Polyhexanide/Betaine Gel Versus Silver Sulfadiazine for Partial-Thickness Burn Treatment.
Wattanaploy S; Chinaroonchai K; Namviriyachote N; Muangman P
Int J Low Extrem Wounds; 2017 Mar; 16(1):45-50. PubMed ID: 28682677
[TBL] [Abstract][Full Text] [Related]
10. Assessing effect of three herbal medicines in second and third degree burns in rats and comparison with silver sulfadiazine ointment.
Akhoondinasab MR; Khodarahmi A; Akhoondinasab M; Saberi M; Iranpour M
Burns; 2015 Feb; 41(1):125-31. PubMed ID: 24907191
[TBL] [Abstract][Full Text] [Related]
11. Prospective comparison of silver sulfadiazine 1 per cent plus chlorhexidine digluconate 0.2 per cent (Silvazine) and silver sulfadiazine 1 per cent (Flamazine) as prophylaxis against burn wound infection.
Inman RJ; Snelling CF; Roberts FJ; Shaw K; Boyle JC
Burns Incl Therm Inj; 1984 Oct; 11(1):35-40. PubMed ID: 6391611
[TBL] [Abstract][Full Text] [Related]
12. Microbial cellulose dressing compared with silver sulphadiazine for the treatment of partial thickness burns: A prospective, randomised, clinical trial.
Aboelnaga A; Elmasry M; Adly OA; Elbadawy MA; Abbas AH; Abdelrahman I; Salah O; Steinvall I
Burns; 2018 Dec; 44(8):1982-1988. PubMed ID: 30005989
[TBL] [Abstract][Full Text] [Related]
13. Benefit of hydrocolloid SSD dressing in the outpatient management of partial thickness burns.
Muangman P; Muangman S; Opasanon S; Keorochana K; Chuntrasakul C
J Med Assoc Thai; 2009 Oct; 92(10):1300-5. PubMed ID: 19845237
[TBL] [Abstract][Full Text] [Related]
14. The effects of octylcyanoacrylate on scarring after burns.
Singer A; Thode H; McClain S
Acad Emerg Med; 2001 Feb; 8(2):107-11. PubMed ID: 11157284
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of silver sulfadiazine, biafine, and saline-soaked gauze in the treatment of superficial partial-thickness burn wounds in pigs.
Glesinger R; Cohen AD; Bogdanov-Berezovsky A; Krieger Y; Rosenberg L
Acad Emerg Med; 2004 Apr; 11(4):339-42. PubMed ID: 15064205
[TBL] [Abstract][Full Text] [Related]
16. Partial-thickness burn wounds healing by topical treatment: A randomized controlled comparison between silver sulfadiazine and centiderm.
Saeidinia A; Keihanian F; Lashkari AP; Lahiji HG; Mobayyen M; Heidarzade A; Golchai J
Medicine (Baltimore); 2017 Mar; 96(9):e6168. PubMed ID: 28248871
[TBL] [Abstract][Full Text] [Related]
17. A Prospective, Randomized, Controlled Trial Comparing the Outpatient Treatment of Pediatric and Adult Partial-Thickness Burns with Suprathel or Mepilex Ag.
Hundeshagen G; Collins VN; Wurzer P; Sherman W; Voigt CD; Cambiaso-Daniel J; Nunez Lopez O; Sheaffer J; Herndon DN; Finnerty CC; Branski LK
J Burn Care Res; 2018 Feb; 39(2):261-267. PubMed ID: 28557869
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of cerium nitrate-silver sulfadiazine in the treatment of facial burns: a multicenter, randomized, controlled trial.
Oen IMMH; van Baar ME; Middelkoop E; Nieuwenhuis MK
Plast Reconstr Surg; 2012 Aug; 130(2):274e-283e. PubMed ID: 22842424
[TBL] [Abstract][Full Text] [Related]
19. Partial-thickness scalds in children: A comparison of different treatment strategies.
de Graaf E; van Baar ME; Baartmans MGA; Scholten-Jaegers SMHJ; Nieuwenhuis MK; Eshuis J; Hiddingh J; Beerthuizen GIJM; van der Vlies CH;
Burns; 2017 Jun; 43(4):733-740. PubMed ID: 28040360
[TBL] [Abstract][Full Text] [Related]
20. Comparison of purified olive oil and silver sulfadiazine in the treatment of partial thickness porcine burns.
Gurfinkel R; Palivatkel-Naim M; Gleisinger R; Rosenberg L; Singer AJ
Am J Emerg Med; 2012 Jan; 30(1):79-83. PubMed ID: 21159471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]